达罗他胺
Tier B — Position earlyDarolutamide · all drugs expiring in 2031 →
Targets:AR
Brand:Nubeqa、诺倍戈
Indications (approved):激素敏感性前列腺肿瘤、去势敏感性前列腺肿瘤、前列腺癌、去势抵抗性前列腺肿瘤
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

| Code | CAS No. | Intermediate |
|---|---|---|
| ODM-201-001 | 154607-01-9Available | 4-bromo-2-chlorobenzonitrile |
| ODM-201-002 | 903550-26-5Available | 1-(tetrahydro-2H-pyran-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole |
| ODM-201-003 | 1297537-35-9Available | 2-chloro-4-(1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl)benzonitrile |
| ODM-201-004 | 1297537-39-3Available | 2-chloro-4-(1H-pyrazol-3-yl)benzonitrile hydrochloride |
| ODM-201-005 | 1297537-37-1Available | 2-chloro-4-(1H-pyrazol-3-yl)benzonitrile |
| ODM-201-006 | 79069-13-9Available | tert-butyl (S)-(1-hydroxypropan-2-yl)carbamate |
| ODM-201-007 | 1297537-41-7Available | (S)-4-(1-(2-aminopropyl)-1H-pyrazol-3-yl)-2-chlorobenzonitrile |
| ODM-201-008 | 1297537-45-1Available | 5-acetyl-1H-pyrazole-3-carboxylic acid |
| ODM-201-009 | 1297537-33-7Available | (S)-5-acetyl-N-(1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propan-2-yl)-1H-pyrazole-3-carboxamide |
Frequently asked questions
What are the approved indications of Darolutamide?
Approved indications include: 激素敏感性前列腺肿瘤, 去势敏感性前列腺肿瘤, 前列腺癌, 去势抵抗性前列腺肿瘤.
When does the Darolutamide patent expire?
Based on public sources, the Darolutamide patent expires in 2031.
How many synthesis routes are recorded for Darolutamide?
1 synthesis routes are recorded; the shortest is 6 steps with 12.2g total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Darolutamide intermediates?
9 intermediate CAS of Darolutamide are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.
How do I get a quote for Darolutamide intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24